Literature DB >> 20397290

Treatment with monoclonal antibodies against Clostridium difficile toxins.

Ainsley E Dawson, Steven L Shumak, Donald A Redelmeier.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20397290

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

Review 1.  Immune-based treatment and prevention of Clostridium difficile infection.

Authors:  Song Zhao; Chandrabali Ghose-Paul; Keshan Zhang; Saul Tzipori; Xingmin Sun
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

Review 2.  Cryptococcal Meningitis and Anti-virulence Therapeutic Strategies.

Authors:  Kiem Vu; Javier A Garcia; Angie Gelli
Journal:  Front Microbiol       Date:  2019-02-26       Impact factor: 5.640

3.  Serum-Derived Bovine Immunoglobulin as Novel Adjunct in Complicated Clostridium difficile Colitis Treatment.

Authors:  Samson Ferm; Nims Varadi; Constantine Fisher; Ellen Gutkin
Journal:  ACG Case Rep J       Date:  2017-05-10

4.  Pathobionts: mechanisms of survival, expansion, and interaction with host with a focus on Clostridioides difficile.

Authors:  Harish Chandra; Krishna Kant Sharma; Olli H Tuovinen; Xingmin Sun; Pratyoosh Shukla
Journal:  Gut Microbes       Date:  2021 Jan-Dec
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.